Drawing for NUCLEOFECTION

USPTO serial 79065366

NUCLEOFECTION

Reviewed by CopyMark Law Group

Reg. 3856843Status 404
Filing date
Status date
Registration date
Oct 5, 2010
Examiner
KAJUBI, ELIZABETH N
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NUCLEOFECTION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David M. Perry

David M. Perry Blank Rome LLPOne Logan Square8th FloorPhiladelphia, PA 19103-6998

Goods and services

ClassDescriptionStatusFirst use
001Chemical and biochemical preparations used in industry and science for the transfer for biological molecules into living cells and the integration of foreign nucleic acids into the genome of living cells; buffer and standard solutions for the transfer of biological molecules into living cells and the integration of foreign nucleic acids into the genome of living cells for scientific and research use; biological agents, namely, buffer and standard solutions containing living cells, proteins, peptides and nucleic acids for laboratory use other than for medical and veterinary purposes; diagnostic preparations other than for medical and veterinary purposes; biological reagents for laboratories, namely, peptides, proteins, nucleic acids and complexes made of peptides, proteins and nucleic acids, for detecting gene expression and localizing proteins as well as for integrating foreign nucleic acids into the genome of living cells for laboratory use, included in this classSECTION 71 - CANCELLED—
005Pharmaceutical preparations for the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; diagnostic preparations for medical and veterinary use; living cells for medical or clinical use in the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; cultures of micro-organisms for medical or clinical use in the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; proteins, peptides, nucleic acid sequences and biochemical reagents of these molecules for medical and veterinary use in the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancerSECTION 71 - CANCELLED—
009Scientific apparatus and instruments, namely, electrical equipment in the nature of electrical field generators and capacitor impulse generators for the transfer of biological molecules into living cells and the integration of foreign nucleic acids into the genome of living cells; apparatus and instruments for electroporation, namely, electroporators and their peripheral equipment; apparatus and instruments for conducting, switching, converting, storing, controlling and monitoring of electricity, namely, electrical capacitors, electrical conductors and electric parameter monitor modules; laboratory equipment and supplies, namely, containers and reaction vessels of the transfer of biological molecules into living cells and the integration of foreign nucleic acids into the genome of living cells; test tubes; electrodes made of metal and conductive polymers; plastic tubes for scientific purposes, namely, laboratory storage tubes; cuvettes, namely, test tubes having electrodes made of metal and conductive polymers for biochemical purposes; multi-well plates having electrodes made of metal and conductive polymers for biochemical purposes; data processors and computers; computer peripherals; computer programs and software recorded on data media designed for use in controlling of scientific apparatus and instruments for the transfer of biological molecules into living cells and the integration of foreign nucleic acids into the genome of living cells, as far as included in this classSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 2, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 14, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 2, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 12, 2019RFNTREFUSAL PROCESSED BY IB—
Oct 26, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Oct 26, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 23, 2018INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jan 25, 2018INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jan 25, 2018INPCINVALIDATION PROCESSED—
Jan 12, 2018INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 12, 2017C71TCANCELLED SECTION 71—
Oct 5, 2015REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 26, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 12, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 9, 2013CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Dec 29, 2012CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Nov 11, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 11, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 5, 2011ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jan 6, 2011FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 6, 2011FIMPFINAL DISPOSITION PROCESSED—
Jan 5, 2011FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 5, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 27, 2010OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 12, 2010OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 12, 2010OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 20, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 30, 2010NPUBNOTICE OF PUBLICATION—
Jun 15, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 15, 2010ALIEASSIGNED TO LIE—
Jun 1, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 1, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 1, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 1, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 9, 2010CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 9, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 19, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 19, 2010ALIEASSIGNED TO LIE—
Mar 9, 2010ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 21, 2010CHLDCHANGE OF OWNER RECEIVED FROM IB—
Sep 15, 2009CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 14, 2009CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 26, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 26, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 26, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 10, 2009RFNTREFUSAL PROCESSED BY IB—
Mar 20, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 18, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 18, 2009RFRRREFUSAL PROCESSED BY MPU—
Mar 18, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 17, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 16, 2009DOCKASSIGNED TO EXAMINER—
Mar 16, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 13, 2009LIMSLIMITATION OF GOODS/SERVICES FROM IB ENTERED—
Mar 12, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance